| http://www.w3.org/ns/prov#value | - About Ablynx Ablynx (Euronext: ABLX) is a biopharmaceutical company engaged in the discovery and development of Nanobodies(??), a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life- threatening human diseases, including inflammation, haematology, oncology and pulmonary disease.
|
